Cytotoxicity: Difference between revisions
mNo edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
Cytotoxicity | |||
[[ | Cytotoxicity refers to the quality of being toxic to cells. It is a critical concept in the fields of [[pharmacology]], [[toxicology]], and [[oncology]], as it pertains to the ability of certain substances or cells to kill or damage cells. Understanding cytotoxicity is essential for the development of new drugs, particularly in cancer treatment, where the goal is to selectively target and destroy cancerous cells while minimizing harm to normal cells. | ||
== Mechanisms of Cytotoxicity == | |||
Cytotoxicity can occur through various mechanisms, including: | |||
* '''[[Apoptosis]]''': A form of programmed cell death that is often triggered by cytotoxic agents. Apoptosis is characterized by cell shrinkage, chromatin condensation, and DNA fragmentation. | |||
* '''[[Necrosis]]''': A form of traumatic cell death resulting from acute cellular injury. Unlike apoptosis, necrosis often results in inflammation. | |||
* '''[[Autophagy]]''': A process where cells degrade their own components through the lysosomal machinery, which can lead to cell death under certain conditions. | |||
== | == Cytotoxic Agents == | ||
Cytotoxic agents can be classified into several categories based on their origin and mechanism of action: | |||
[[ | * '''[[Chemical agents]]''': These include drugs such as [[chemotherapy]] agents that are used to treat cancer. Examples include [[doxorubicin]], [[cisplatin]], and [[paclitaxel]]. | ||
* '''[[Biological agents]]''': These include [[monoclonal antibodies]] and [[cytokines]] that can induce cell death in specific cell types. | |||
* '''[[Physical agents]]''': Such as radiation, which can cause DNA damage leading to cell death. | |||
== Measuring Cytotoxicity == | |||
Several assays are used to measure cytotoxicity in vitro, including: | |||
* '''[[MTT assay]]''': A colorimetric assay that measures cell metabolic activity as an indicator of cell viability, proliferation, and cytotoxicity. | |||
* '''[[LDH release assay]]''': Measures the release of lactate dehydrogenase from damaged cells, indicating cell membrane integrity. | |||
* '''[[Flow cytometry]]''': Used to assess cell death by measuring markers such as annexin V and propidium iodide. | |||
* | |||
* | |||
== | == Clinical Applications == | ||
Cytotoxicity is | Cytotoxicity is a key consideration in the development of new therapeutic agents. In cancer therapy, the goal is to maximize the cytotoxic effect on cancer cells while minimizing damage to normal cells. This requires a deep understanding of the mechanisms of action of cytotoxic agents and the cellular pathways involved in cell death. | ||
== | == Challenges and Considerations == | ||
One of the major challenges in the use of cytotoxic agents is the development of resistance by cancer cells. This can occur through various mechanisms, such as increased drug efflux, enhanced DNA repair, and alterations in cell death pathways. Overcoming resistance is a major focus of current research in cancer therapy. | |||
== | == Also see == | ||
* [[Apoptosis]] | |||
* | * [[Chemotherapy]] | ||
* | * [[Toxicology]] | ||
* [[Oncology]] | |||
* [[Cell death]] | |||
{{Medical-stub}} | |||
[[Category:Cell | [[Category:Cell biology]] | ||
[[Category:Toxicology]] | [[Category:Toxicology]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 19:05, 11 December 2024
Cytotoxicity
Cytotoxicity refers to the quality of being toxic to cells. It is a critical concept in the fields of pharmacology, toxicology, and oncology, as it pertains to the ability of certain substances or cells to kill or damage cells. Understanding cytotoxicity is essential for the development of new drugs, particularly in cancer treatment, where the goal is to selectively target and destroy cancerous cells while minimizing harm to normal cells.
Mechanisms of Cytotoxicity[edit]
Cytotoxicity can occur through various mechanisms, including:
- Apoptosis: A form of programmed cell death that is often triggered by cytotoxic agents. Apoptosis is characterized by cell shrinkage, chromatin condensation, and DNA fragmentation.
- Necrosis: A form of traumatic cell death resulting from acute cellular injury. Unlike apoptosis, necrosis often results in inflammation.
- Autophagy: A process where cells degrade their own components through the lysosomal machinery, which can lead to cell death under certain conditions.
Cytotoxic Agents[edit]
Cytotoxic agents can be classified into several categories based on their origin and mechanism of action:
- Chemical agents: These include drugs such as chemotherapy agents that are used to treat cancer. Examples include doxorubicin, cisplatin, and paclitaxel.
- Biological agents: These include monoclonal antibodies and cytokines that can induce cell death in specific cell types.
- Physical agents: Such as radiation, which can cause DNA damage leading to cell death.
Measuring Cytotoxicity[edit]
Several assays are used to measure cytotoxicity in vitro, including:
- MTT assay: A colorimetric assay that measures cell metabolic activity as an indicator of cell viability, proliferation, and cytotoxicity.
- LDH release assay: Measures the release of lactate dehydrogenase from damaged cells, indicating cell membrane integrity.
- Flow cytometry: Used to assess cell death by measuring markers such as annexin V and propidium iodide.
Clinical Applications[edit]
Cytotoxicity is a key consideration in the development of new therapeutic agents. In cancer therapy, the goal is to maximize the cytotoxic effect on cancer cells while minimizing damage to normal cells. This requires a deep understanding of the mechanisms of action of cytotoxic agents and the cellular pathways involved in cell death.
Challenges and Considerations[edit]
One of the major challenges in the use of cytotoxic agents is the development of resistance by cancer cells. This can occur through various mechanisms, such as increased drug efflux, enhanced DNA repair, and alterations in cell death pathways. Overcoming resistance is a major focus of current research in cancer therapy.
Also see[edit]
